Literature DB >> 22811844

Can pancreaticoduodenectomy performed at a comprehensive community cancer center have comparable results as major tertiary center?

Charles Cheng1, David Duppler, Boguslawa Koczon Jaremko.   

Abstract

BACKGROUND: Pancreatic resection is a definitive treatment modality for pancreatic neoplasm. Pancreaticoduodenectomy (PD) is the primary procedure for tumor arising from head of pancreas. Prognosis is overwhelmingly poor despite adequate resection. We maintained a prospective database covering years 2001 to 2010. Outcome data is analyzed and compared with those from tertiary centers.
METHODS: Sixty-two patients with various histology were included. Pylorus preserving pancreatico-duodenectomy (PPPD), classic pancreaticoduodenectomy, and subtotal pancreatectomy were procedures performed. Three patients had portal venorrhaphy performed to obtain clinically negative margin. Forty six patients had malignancy on final pathologic analysis.
RESULTS: The average age of patients was 63. Mean preoperative CA19-9 for exocrine pancreatic malignancies was higher than for more benign lesions. There was a decrease in operative time during this period. Blood transfusion was uncommon. There was very few pancreatic leak among the patients. Two bile leaks were identified, one controlled with the drainage tube and the other one required repeat surgery. The primary reason for the prolonged hospitalization was gastric ileus. For patients without a gastrostomy tube, nasogastric tube was kept in until gastric ileus resolved. 30 days mortality rate was calculated at 4.8. Mean survival time during our follow up was 30.6 months. Comparing to published literature, present series' mortality, morbidity, and survival are similar. Five year survival was 39%.
CONCLUSION: Despite overall poor outcome for patients with pancreatic and biliary malignancies, we conclude that surgery can be performed in community hospitals with special interest in treating pancreatic disorder, offering patients equivalent survival and quality of life as those operated in tertiary centers.

Entities:  

Keywords:  community hospital; pancreaticoduodenectomy for pancreatic cancer; surgical outcome

Year:  2011        PMID: 22811844      PMCID: PMC3397611          DOI: 10.3978/j.issn.2078-6891.2011.035

Source DB:  PubMed          Journal:  J Gastrointest Oncol        ISSN: 2078-6891


  23 in total

1.  National estimates of mortality rates for radical pancreaticoduodenectomy in 25,000 patients.

Authors:  Cyrus A Kotwall; J Gary Maxwell; Carla C Brinker; Gary G Koch; Deborah L Covington
Journal:  Ann Surg Oncol       Date:  2002-11       Impact factor: 5.344

2.  Refinement of adjuvant therapy for pancreatic cancer.

Authors:  Eileen M O'Reilly
Journal:  JAMA       Date:  2010-09-08       Impact factor: 56.272

Review 3.  Pancreatic cancer.

Authors:  Randall Brand
Journal:  Dis Mon       Date:  2004-10       Impact factor: 3.800

4.  One thousand consecutive pancreaticoduodenectomies.

Authors:  John L Cameron; Taylor S Riall; JoAnn Coleman; Kenneth A Belcher
Journal:  Ann Surg       Date:  2006-07       Impact factor: 12.969

Review 5.  Biology and management of pancreatic cancer.

Authors:  Paula Ghaneh; Eithne Costello; John P Neoptolemos
Journal:  Gut       Date:  2007-08       Impact factor: 23.059

6.  SURGICAL MANAGEMENT OF CARCINOMA OF THE AMPULLA OF VATER AND OF THE PERIAMPULLARY PORTION OF THE DUODENUM.

Authors:  V C Hunt
Journal:  Ann Surg       Date:  1941-10       Impact factor: 12.969

7.  TREATMENT OF CARCINOMA OF THE AMPULLA OF VATER.

Authors:  A O Whipple; W B Parsons; C R Mullins
Journal:  Ann Surg       Date:  1935-10       Impact factor: 12.969

8.  Long-term survival is superior after resection for cancer in high-volume centers.

Authors:  Yuman Fong; Mithat Gonen; David Rubin; Mark Radzyner; Murray F Brennan
Journal:  Ann Surg       Date:  2005-10       Impact factor: 12.969

9.  The learning curve in pancreatic surgery.

Authors:  Jennifer F Tseng; Peter W T Pisters; Jeffrey E Lee; Huamin Wang; Henry F Gomez; Charlotte C Sun; Douglas B Evans
Journal:  Surgery       Date:  2007-01-22       Impact factor: 3.982

10.  Long-term survival after curative resection for pancreatic ductal adenocarcinoma. Clinicopathologic analysis of 5-year survivors.

Authors:  K C Conlon; D S Klimstra; M F Brennan
Journal:  Ann Surg       Date:  1996-03       Impact factor: 12.969

View more
  1 in total

1.  Pancreatic cancer: current standards, research updates and future directions.

Authors:  Chung-Tsen Hsueh
Journal:  J Gastrointest Oncol       Date:  2011-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.